(Q53737209)

18 May 2018

title

Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation. (English)

1 reference

18 May 2018

3

Lokhorst HM

1 reference

18 May 2018

author name string

Meijer E

1

1 reference

18 May 2018

Dekker AW

2

1 reference

18 May 2018

Petersen EJ

4

1 reference

18 May 2018

Nieuwenhuis HK

5

1 reference

18 May 2018

Verdonck LF

6

1 reference

18 May 2018

publication date

1 December 2004

1 reference

18 May 2018

Transplant Infectious Disease

published in

1 reference

18 May 2018

volume

6

1 reference

18 May 2018

issue

4

1 reference

18 May 2018

page(s)

171-178

1 reference

18 May 2018

Hematopoietic stem cell transplantation for hematological malignancies in Europe.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

Strategies to reduce transplant-related mortality after allogeneic stem cell transplantation in elderly patients: Comparison of reduced-intensity conditioning and unmanipulated peripheral blood stem cells vs a myeloablative regimen and CD34+ cell se

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

Immune Reconstitution and Early Infectious Complications Following Nonmyeloablative Hematopoietic Stem Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

Diagnosing herpesvirus infections by real-time amplification and rapid culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00075.X

10.1111/J.1399-3062.2004.00075.X

21 January 2018

Identifiers

DOI

1 reference

18 May 2018

1 reference

18 May 2018